Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1994 May;70(5):410–412. doi: 10.1136/adc.70.5.410

Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.

B Wilcken 1, J Hammond 1, M Silink 1
PMCID: PMC1029830  PMID: 8017963

Abstract

Medium chain acyl coenzyme A dehydrogenase (MCAD) deficiency presents with episodic fasting, hypoketotic hypoglycaemia, and coma. It is known to be potentially lethal, but the outlook for survivors is thought to be good. We reassessed all patients with MCAD deficiency diagnosed in New South Wales (population six million) to explore long term morbidity and mortality. There were 16 probands and two siblings were confirmed and two presumed to be affected. Assuming an incidence of 1:20,000 births, these represented about 22% of the total number of expected cases. Five (25%) of the 20 patients died aged 3 days-30 months, all during the first episode of illness. Seven others had only one episode and one affected sibling was asymptomatic. Eight had had significant neonatal symptoms. Only two had a significant, serious life threatening episode after diagnosis. Of 15 survivors, one has severe handicap after a single severe episode, and four, aged 9-17 years, have mild intellectual handicap. Eight (including six aged less than 7 years), have apparently normal development. Two are lost to follow up. Our study of unselected patients with MCAD deficiency from a defined population shows not only a substantial risk of death, but also of long term morbidity.

Full text

PDF
410

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gregersen N., Winter V., Curtis D., Deufel T., Mack M., Hendrickx J., Willems P. J., Ponzone A., Parrella T., Ponzone R. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: the prevalent mutation G985 (K304E) is subject to a strong founder effect from northwestern Europe. Hum Hered. 1993 Nov-Dec;43(6):342–350. doi: 10.1159/000154157. [DOI] [PubMed] [Google Scholar]
  2. Leung K. C., Hammond J. W., Chabra S., Carpenter K. H., Potter M., Wilcken B. A fatal neonatal case of medium-chain acyl-coenzyme A dehydrogenase deficiency with homozygous A-->G985 transition. J Pediatr. 1992 Dec;121(6):965–968. doi: 10.1016/s0022-3476(05)80353-1. [DOI] [PubMed] [Google Scholar]
  3. Matsubara Y., Narisawa K., Tada K., Ikeda H., Yao Y. Q., Danks D. M., Green A., McCabe E. R. Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards. Lancet. 1991 Aug 31;338(8766):552–553. doi: 10.1016/0140-6736(91)91110-g. [DOI] [PubMed] [Google Scholar]
  4. Seakins J. W., Rumsby G. The use of phenylpropionic acid as a loading test for medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 1988;11 (Suppl 2):221–224. doi: 10.1007/BF01804241. [DOI] [PubMed] [Google Scholar]
  5. Touma E. H., Charpentier C. Medium chain acyl-CoA dehydrogenase deficiency. Arch Dis Child. 1992 Jan;67(1):142–145. doi: 10.1136/adc.67.1.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Truscott R. J., Hick L., Pullin C., Halpern B., Wilcken B., Griffiths H., Silink M., Kilham H., Grunseit F. Dicarboxylic aciduria: the response to fasting. Clin Chim Acta. 1979 May 16;94(1):31–39. doi: 10.1016/0009-8981(79)90183-9. [DOI] [PubMed] [Google Scholar]
  7. Wilcken B., Carpenter K. H., Hammond J. Neonatal symptoms in medium chain acyl coenzyme A dehydrogenase deficiency. Arch Dis Child. 1993 Sep;69(3 Spec No):292–294. doi: 10.1136/adc.69.3_spec_no.292. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES